BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18061869)

  • 21. Prophylactic HPV vaccines: new interventions for cancer control.
    Barr E; Sings HL
    Vaccine; 2008 Nov; 26(49):6244-57. PubMed ID: 18694795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing patient risk for human papillomavirus infection and cervical cancer.
    Herbert J; Coffin J
    J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus and lower genital neoplasia in renal transplant patients.
    Halpert R; Fruchter RG; Sedlis A; Butt K; Boyce JG; Sillman FH
    Obstet Gynecol; 1986 Aug; 68(2):251-8. PubMed ID: 3016625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of human papillomavirus with vulvar and vaginal intraepithelial disease: opportunities for prevention.
    Pearson JM; Feltman RS; Twiggs LB
    Womens Health (Lond); 2008 Mar; 4(2):143-50. PubMed ID: 19072516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors.
    Xu L; Selk A; Garland SM; Bogliatto F; Kyrgiou M; Weyers S; Arbyn M
    Expert Rev Vaccines; 2019 Nov; 18(11):1157-1166. PubMed ID: 31718338
    [No Abstract]   [Full Text] [Related]  

  • 26. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Few More Reasons to Vaccinate Against Human Papillomavirus: The Vulva and Vagina.
    Feldman S
    Obstet Gynecol; 2018 Aug; 132(2):259-260. PubMed ID: 29995721
    [No Abstract]   [Full Text] [Related]  

  • 28. Vulvar and vaginal cancers as seen at the University College Hospital Ibadan, Nigeria.
    Babarinsa LA; Fakokunde FA; Ogunbiyi JO; Adewole IF
    Afr J Med Med Sci; 1999; 28(1-2):77-80. PubMed ID: 12953992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB
    Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J; Lehtinen M
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 34. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Three cases of vaginal adenosis after topical 5-fluorouracil therapy for vaginal HPV-associated lesions].
    Georgiev D; Karag'ozov I; Velev M; Makaveeva V
    Akush Ginekol (Sofiia); 2006; 45(3):59-61. PubMed ID: 16889191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.
    Kahn JA; Ding L; Huang B; Zimet GD; Rosenthal SL; Frazier AL
    Pediatrics; 2009 Jun; 123(6):1439-45. PubMed ID: 19482752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment on the Article: Srodon M, Stoler MH, Baber GB, et al. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN) Am J Surg Pathol. 2006;30:1513-1518.
    Sideri M; Jones RW; Heller DS; Haefner H; Neill S; Preti M; Scurry J; Wilkinson EJ; Edwards L
    Am J Surg Pathol; 2007 Sep; 31(9):1452; author reply 1452--4. PubMed ID: 17721204
    [No Abstract]   [Full Text] [Related]  

  • 40. Vulvar intraepithelial neoplasia.
    Caglar H; Tamer S; Hreshchyshyn MM
    Obstet Gynecol; 1982 Sep; 60(3):346-9. PubMed ID: 7121915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.